Anaplastic (Malignant) Meningioma — Trials

Anaplastic (Malignant) Meningioma — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 50%
Top sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03016091	A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma	terminated	Phase 2	18	Rabin Medical CenterOTHER	1	Feb 18, 2025	clinicaltrials
NCT00003292	S9624 Ifosfamide in Treating Patients With Meningeal Tumors	terminated	Phase 2	7	SWOG Cancer Research NetworkNETWORK	4	Nov 8, 2013	clinicaltrials